Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, risk and profitability.
Volatility and Risk
Strata Skin Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.38, meaning that its share price is 338% less volatile than the S&P 500.
Insider and Institutional Ownership
32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 3.8% of MSP Recovery shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 50.5% of MSP Recovery shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Strata Skin Sciences | 1 | 0 | 0 | 0 | 1.00 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares Strata Skin Sciences and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Strata Skin Sciences | -35.64% | -476.73% | -33.49% |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
Valuation & Earnings
This table compares Strata Skin Sciences and MSP Recovery”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Strata Skin Sciences | $30.98 million | 0.02 | -$10.09 million | ($1.41) | -0.09 |
| MSP Recovery | $9.81 million | 0.03 | -$360.50 million | ($572.83) | 0.00 |
Strata Skin Sciences has higher revenue and earnings than MSP Recovery. Strata Skin Sciences is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Summary
Strata Skin Sciences beats MSP Recovery on 7 of the 11 factors compared between the two stocks.
About Strata Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
